Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neha Rohatgi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2026
Mapping the dialogue: Decoding alveolar stem-niche interactionsAhmad N Nabhan, Anne Biton, Christine Everett, et al.
Cancer Immunology Research|November 21, 2022
CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic CancerCélia Jacoberger-Foissac, Isabelle Cousineau, Yacine Bareche, et al.
Ebiomedicine|April 16, 2021
Corrigendum to 'A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)'Joo-Leng Low, Dawn Pingxi Lau, Xiaoqian Zhang, et al.
Ebiomedicine|February 2, 2021
A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)Joo-Leng Low, Dawn Pingxi Lau, Xiaoqian Zhang, et al.
Gene Regulation and Systems Biology|July 19, 2016
Community-Reviewed Biological Network Models for Toxicology and Drug Discovery Applications, Aishwarya Alex Namasivayam, Alejandro Ferreiro Morales, et al.
JTO Clinical and Research Reports|November 25, 2022
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCGillianne G Y Lai, Jia Chi Yeo, Amit Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic OpportunitiesKhi Pin Chua, Yvonne H F Teng, Aaron C Tan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2026
Mapping the dialogue: Decoding alveolar stem-niche interactionsAhmad N Nabhan, Anne Biton, Christine Everett, et al.
Cancer Immunology Research|November 21, 2022
CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic CancerCélia Jacoberger-Foissac, Isabelle Cousineau, Yacine Bareche, et al.
Ebiomedicine|April 16, 2021
Corrigendum to 'A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)'Joo-Leng Low, Dawn Pingxi Lau, Xiaoqian Zhang, et al.
Ebiomedicine|February 2, 2021
A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)Joo-Leng Low, Dawn Pingxi Lau, Xiaoqian Zhang, et al.
Gene Regulation and Systems Biology|July 19, 2016
Community-Reviewed Biological Network Models for Toxicology and Drug Discovery Applications, Aishwarya Alex Namasivayam, Alejandro Ferreiro Morales, et al.
JTO Clinical and Research Reports|November 25, 2022
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLCGillianne G Y Lai, Jia Chi Yeo, Amit Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic OpportunitiesKhi Pin Chua, Yvonne H F Teng, Aaron C Tan, et al.
Pageof 2